Literature DB >> 18655891

Functional magnetic resonance imaging and the neurobiology of vasopressin and oxytocin.

Craig F Ferris1.   

Abstract

Functional magnetic resonance imaging is used to assess the roles of vasopressin (AVP) in aggressive motivation and oxytocin (OXT) in maternal behaviour. In the case of aggression, male rats are triggered to show the autonomic signs of impending attack behaviour by simulating a resident/intruder conflict in the bore of the magnet during the imaging session. Intraventricular injection of AVP alone causes robust changes in brain activity mirroring many areas selective for AVP receptor binding and overlapped with many of the same areas activated during aggression. Pretreatment with an orally active AVP V1a receptor antagonist blocks aggression in bench-top studies and suppressed the pattern of brain activation caused by the intruder or administration of AVP. These findings using imaging corroborate and extended our understanding of the neural circuitry of aggression and the role of AVP neurotransmission in agonistic motivation. In the case of maternal behaviour, primiparous dams are imaged during nursing with and without OXT receptor blockade. Suckling alone activates many cortical and subcortical areas. Intracerebroventricular injection of OXT stimulates brain activity in areas selective to OXT receptor binding and overlap with many of the same areas activated during pup suckling. Pretreatment with OXT receptor antagonist suppresses the pattern of brain activation caused by suckling or administration of OXT. The data suggest that OXT may strengthen mother-infant bond formation partly by acting through brain areas involved in regulating olfactory discrimination, emotions and reward.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655891     DOI: 10.1016/S0079-6123(08)00425-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  15 in total

1.  The biochemistry of love: an oxytocin hypothesis.

Authors:  C Sue Carter; Stephen W Porges
Journal:  EMBO Rep       Date:  2012-11-27       Impact factor: 8.807

2.  Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Lauren L Drogos; S Kristian Hill; Anthony C Ruocco; Sarah K Keedy; James L Reilly; Matcheri S Keshavan; Godfrey D Pearlson; Carol A Tamminga; Elliot S Gershon; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-03-11       Impact factor: 9.306

Review 3.  Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.

Authors:  Rebekah Wigton; Jocham Radua; Paul Allen; Bruno Averbeck; Andreas Meyer-Lindenberg; Philip McGuire; Sukhi S Shergill; Paolo Fusar-Poli
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

Review 4.  Oxytocin and vasopressin modulation of the neural correlates of motivation and emotion: results from functional MRI studies in awake rats.

Authors:  Marcelo Febo; Craig F Ferris
Journal:  Brain Res       Date:  2014-01-30       Impact factor: 3.252

5.  Hormonal mechanisms for regulation of aggression in human coalitions.

Authors:  Mark V Flinn; Davide Ponzi; Michael P Muehlenbein
Journal:  Hum Nat       Date:  2012-03

6.  Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.

Authors:  Alberto Galbusera; Alessia De Felice; Stefano Girardi; Giacomo Bassetto; Marta Maschietto; Katsuhiko Nishimori; Bice Chini; Francesco Papaleo; Stefano Vassanelli; Alessandro Gozzi
Journal:  Neuropsychopharmacology       Date:  2016-12-20       Impact factor: 7.853

7.  Oxytocin enhances the perception of biological motion in humans.

Authors:  Szabolcs Kéri; György Benedek
Journal:  Cogn Affect Behav Neurosci       Date:  2009-09       Impact factor: 3.282

8.  Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis.

Authors:  Leah H Rubin; C Sue Carter; Jeffrey R Bishop; Hossein Pournajafi-Nazarloo; Margret S H Harris; Scot K Hill; James L Reilly; John A Sweeney
Journal:  Schizophr Res       Date:  2013-03-07       Impact factor: 4.939

9.  The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats.

Authors:  C Hicks; W Jorgensen; C Brown; J Fardell; J Koehbach; C W Gruber; M Kassiou; G E Hunt; I S McGregor
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

Review 10.  The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

Authors:  Guillaume Fond; Marc-Antoine d'Albis; Stéphane Jamain; Ryad Tamouza; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Markus Leweke; Shôn Lewis; Phillip McGuire; Andreas Meyer-Lindenberg; Iris E Sommer; Inge Winter-van Rossum; Shitij Kapur; René S Kahn; Dan Rujescu; Marion Leboyer
Journal:  Schizophr Bull       Date:  2015-03-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.